I now have comprehensive content across all three parts. Here is the complete structured answer:
METs, Functional Capacity Assessment in Coronary Stent Patients, and Cardiac Biomarkers [2+4+4]
PART 1: What is METs? [2 marks]
Metabolic Equivalent of Task (MET) is a unit that expresses the energy cost of a physical activity as a multiple of the resting metabolic rate.
- 1 MET = 3.5 mL O2/kg/min - the resting oxygen consumption of a 40-year-old, 70 kg adult sitting quietly (approximately 1.2 kcal/min)
- It quantifies functional capacity - the maximum sustainable physical work a patient can perform
- Each additional MET generated is associated with a 13% reduction in all-cause mortality and a 15% reduction in long-term cardiovascular events in healthy individuals
MET scale:
| METs | Activity |
|---|
| 1 | Resting, eating, dressing, watching TV |
| 2-3 | Walking at 3 km/hr, light housework |
| 4 | Climbing one flight of stairs, golf, dancing - KEY threshold |
| 6 | Short run |
| >10 | Strenuous sport - tennis, football, skiing |
(Sabiston Textbook of Surgery; Morgan & Mikhail, 7th Ed.)
PART 2: Recent Guidelines for Assessment of Functional Capacity in a Patient with Coronary Stents [4 marks]
A. Timing of Surgery After Stent Placement (ACC/AHA 2014)
This is the first decision before any functional assessment:
| Intervention | Minimum Wait Before Elective Surgery |
|---|
| Balloon angioplasty (no stent) | 14 days |
| Bare Metal Stent (BMS) | 30 days |
| Drug-Eluting Stent (DES) | 12 months (6 months if risk of delay > risk of MACE) |
Coronary stent placement within 1 year of noncardiac surgery is an independent risk factor for perioperative MACE and bleeding. Early surgery after DES is dangerous due to stent thrombosis risk from premature discontinuation of DAPT in the setting of non-endothelialized stent surfaces. - Barash's Clinical Anesthesia, 9th Ed.
The flowchart below (from Barash) summarizes the perioperative approach:
B. Methods of Functional Capacity Assessment
Once the timing is appropriate, functional capacity is assessed using the following hierarchy (ACC/AHA, CCS, and ESC 2022 guidelines):
1. Subjective Clinical Interview (least accurate)
- Ask about daily activities and estimate METs
- Major limitation: sensitivity for detecting inability to achieve ≥4 METs is only 19% (specificity 95%) - Miller's Anesthesia, 10th Ed.
- Structured questions are better: "Can you climb two flights of stairs?" or "Can you walk four blocks?"
- Inability to climb a flight of stairs (~4 METs) predicts a postoperative cardiopulmonary complication with 89% accuracy
2. Validated Questionnaires (preferred structured approach)
- DASI (Duke Activity Status Index): 12-item self-administered questionnaire; DASI score ≤25 correlates with significantly increased risk of postoperative MI and major complications
- MET-REPAIR questionnaire (MET: REvaluation for Perioperative cArdIac Risk): patients self-report activities from the previous month; the highest activity performed determines the estimated MET level
- Both correlate well with gold-standard CPET; ESC 2022 recommends these over unstructured interviews
3. Objective Exercise Testing
| Test | Threshold for High Risk |
|---|
| CPET (Gold Standard) | AT <11 mL/kg/min OR VO2 peak <15 mL/kg/min |
| 6-Minute Walk Test | Poor distance = elevated risk |
| Incremental Shuttle Walk Test | Failure to achieve 350 metres = high risk |
- CPET is recommended for stent patients undergoing high-risk surgery (major vascular, thoracic, abdominal)
- Resting LVEF is NOT a proxy for functional capacity - exercise capacity varies widely even among patients with similar LVEF
4. ACC/AHA Algorithm: The 4-MET Cut-Off
- ≥4 METs (moderate-to-excellent capacity) → Proceed to surgery; no further cardiac testing required
- <4 METs or unknown capacity → Consider stress testing or cardiac catheterization only if results will change management (e.g., revascularization, medical optimization, or choosing a non-surgical alternative)
ESC 2022 adds: For patients with known CVD, risk factors, or age ≥65 undergoing intermediate or high-risk surgery - mandates functional capacity assessment + ECG + cardiac biomarkers together, not functional capacity alone.
PART 3: Role of Cardiac Biomarkers in This Patient [4 marks]
Cardiac biomarkers in a patient with coronary stents serve roles in preoperative risk stratification, intraoperative/postoperative monitoring, and detecting perioperative myocardial injury (MINS).
A. Natriuretic Peptides - BNP and NT-proBNP (Preoperative Role)
Secreted by cardiac ventricles in response to wall stretch and ischemia. They measure a different patient characteristic than functional capacity (only slight-to-fair correlation between natriuretic peptides and exercise capacity). - Miller's Anesthesia
CCS (Canadian Cardiovascular Society) Guidelines recommend BNP/NT-proBNP for preoperative risk stratification when RCRI score is ≥1:
| Biomarker | Low Cardiac Risk | Elevated Cardiac Risk |
|---|
| BNP | <100 pg/mL | >250 pg/mL |
| NT-proBNP | <100 pg/mL | >200 pg/mL |
- Natriuretic peptides improve risk estimation beyond clinical risk factors alone (RCRI)
- AHA/ACC 2014: BNP measurement is not yet formally recommended as routine; no BNP-based management strategy has been proven to reduce cardiovascular risk in RCTs
- ESC 2022: Recommends preoperative high-sensitivity troponin AND natriuretic peptides for any patient with known CVD or risk factors undergoing intermediate/high-risk surgery - used to trigger echocardiography and stress imaging if elevated
B. Troponin - Preoperative and Postoperative Roles
Preoperative:
- AHA/ACC: Measure troponin only when signs or symptoms suggest myocardial ischemia; routine screening of asymptomatic patients is not recommended
- ESC 2022: Recommends high-sensitivity troponin preoperatively in patients with CVD, risk factors, or age ≥65 undergoing intermediate/high-risk surgery as part of a bundle assessment
Postoperative (CCS Guidelines - Highest Yield):
- Routine troponin surveillance for 48-72 hours postoperatively is recommended for patients not classified as low cardiac risk by preoperative BNP/NT-proBNP
- Myocardial injury after noncardiac surgery (MINS) - troponin elevation even without symptoms - is associated with a significant increase in 30-day mortality
- Peak troponin elevation occurs 1-2 days after surgery, and the majority of patients with perioperative myocardial injury are asymptomatic
C. Special Considerations in Stent Patients
- Perioperative hypercoagulability from surgical stress in the setting of non-endothelialized stent surfaces drives the elevated risk of MACE
- Postoperative MI may present as silent troponin leak (no chest pain) due to analgesia and sedation - making troponin surveillance even more critical
- If surgery must be performed on DAPT, the risk of stent thrombosis vs. bleeding must be individualized; at minimum, aspirin should be continued perioperatively
- P2Y12 inhibitors (clopidogrel, ticagrelor) - if stopped, restart as soon as possible postoperatively
- For nonelective surgery, a multidisciplinary consensus among the anesthesiologist, surgeon, cardiologist, and intensivist is mandatory - Barash's Clinical Anesthesia, 9th Ed.
Summary Table: Biomarkers in a Stent Patient
| Biomarker | When | Purpose |
|---|
| BNP / NT-proBNP | Preoperative | Risk stratification; low BNP allows proceeding without further testing |
| hs-Troponin | Preoperative (ESC 2022) | Identifies elevated baseline risk; guides echocardiography referral |
| Troponin | Postoperative (48-72 h) | Detects MINS; asymptomatic elevation still predicts 30-day mortality |
(Miller's Anesthesia, 10th Ed.; Barash's Clinical Anesthesia, 9th Ed.; Fuster and Hurst's The Heart, 15th Ed.; Harrison's 22nd Ed.)